|
 | Up a level |
Tomar, Vivek Singh and Patil, Vikas and Somasundaram, Kumaravel (2019) Temozolomide induces activation of Wnt/beta-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. In: CELL BIOLOGY AND TOXICOLOGY .
Singh, Siddharth and Kumar, Manoj and Kumar, Sanjeev and Sen, Shrinka and Upadhyay, Pawan and Bhattacharjee, Sayan and Naveen, M and Tomar, Vivek Singh and Roy, Siddhartha and Dutt, Amit and Kundu, Tapas K (2019) The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis. In: JOURNAL OF BIOLOGICAL CHEMISTRY, 294 (38). pp. 14081-14095.
Tomar, Vivek Singh and Baral, Tapan Kumar and Nagavelu, Krishnaveni and Somasundaram, Kumaravel (2019) Serine/threonine/tyrosine-interacting-like protein 1 (STYXL1), a pseudo phosphatase, promotes oncogenesis in glioma. In: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 515 (1). pp. 241-247.
Arora, Anjali and Tomar, Vivek Singh and Thomas, Sannu and Patil, Vikas and Hoheisel, Joerg and Somasundaram, Kumaravel (2018) Pooled shRNA screen uncovered the role of SEL1L, an ERAD (endoplasmic reticulum associated degradation) gene, in modulating temozolomide resistance in GBM. In: CANCER RESEARCH, 78 (13, S).
